Porosity-Controlled Ethylcellulose Film Coating. III. Application of Porous Ethylcellulose Film Coating to Capsule-Type Controlled Release Preparation of Theophylline
スポンサーリンク
概要
- 論文の詳細を見る
Porous ethylcellulose (EC) film coating technique was used in preparing a capsule-type controlled release dosage form, in which theophylline (TP) was used as a poorly water-soluble model drug. The TP-loaded uncoated beads were spray-coated with an aqueous ethanolic or ethanolic EC solution, and the drug release characteristics and productivity of each product were examined. When the aqueous ethanol was used as the solvent of the coating solution, a large number of micropores were formed in the coating, and the porosity of coating and drug release rate could be controlled by altering the ethanolic concentration in the coating solution. In addition, few agglomerates were produced in the coating process, even though there was no anti-agglomeration agent in the coating solution. The drug release rate from the coated beads could be changed by film porosity as well as film thickness. Superposition analysis revealed that the EC-coated beads with different film porosities or different coating levels had the same drug release mechanism. It was further found that the drug release behavior of the porous EC film-coated beads was not affected by any simulated physiological conditions such as pH, surface tension, ionic strength or paddle rotation speed, indicating that in vivo drug release should not be affected by such physiological conditions in the gastrointestinal tract.
- 社団法人日本薬学会の論文
- 1994-07-15
著者
-
野田 和夫
Pharmaceutics Research Laboratory, Tanabe Seiyaku Co., Ltd.,
-
吉野 廣祐
Pharmaceutics Research Laboratory Tanabe Seiyaku Co. Ltd.
-
吉野 広祐
田辺製薬
-
平川 善行
Pharmaceutics Research Laboratory Tanabe Seiyaku Co. Ltd.
-
平川 善行
Faculty Of Pharmaceutical Sciences Kyushu University
-
成澤 真治
Pharmaceutics Research Laboratory, Tanabe Seiyaku Co., Ltd.,
-
野田 和夫
Pharmaceutics Research Laboratory Tanabe Seiyaku Co. Ltd.
-
成澤 真治
Pharmaceutics Research Laboratory Tanabe Seiyaku Co. Ltd.
関連論文
- Enhancement of Bioavailability of Dopamine via Nasal Route in Beagle Dogs
- Kinetics of Conversion of Diacetylacetone in Aqueous Solution
- Factors Effecting Spherical Granulation of Drugs by Tumbling Granulation Method
- Estimation of Polymorphic Transition Degree of Pharmaceutical Raw Materials
- Porosity-Controlled Ethylcellulose Film Coating. V. Mechanism of Drug Release from Beads Coated with Porous Ethylcellulose Film
- Porosity-Controlled Ethylcellulose Film Coating. IV. Evaluation of Mechanical Strength of Porous Ethylcellulose Film
- Porosity-Controlled Ethylcellulose Film Coating. III. Application of Porous Ethylcellulose Film Coating to Capsule-Type Controlled Release Preparation of Theophylline
- Porosity-Controlled Ethylcellulose Film Coating. I.Formation of Porous Ethylcellulose Film in the Casting Process and Factors Affecting Film-Density
- Influence of Compression Force on Consolidation Behavior and Drug Release Property of Wax Matrix Tablets
- Influence of Internal Structure on Kinetics of Drug Release from Wax Matrix Tablets
- Influence of Tabletting Speed on Compactibility and Compressibility of Two Direct Compressible Powders under High Speed Compression
- Influence of Fatty Acid Composition on the Properties and Polymorphic Transition of Fatty Suppository Bases
- Influence of the Liquid Phase Coexisting in Fatty Suppository Bases on the Polymorphic Transition Rate
- The Influence of Drugs on the Physical Stability of Fatty Suppositories
- Polymorphic Transition Rate of Semisynthetic Fatty Suppository Bases
- Laser Diffraction Estimation of Particle Size Distribution of Slightly Water-Soluble Drugs Coexisting with Additives : Application to Solid Dosage Forms
- Absorption of Diltiazem in Beagle Dog from Pulsatile Release Tablet
- Design and Preparation of Pulsatile Release Tablet as a New Oral Drug Delivery System
- Improvement of Drugs by Molecular Modification Method. I. Synthesis and Biological Activity of Testosterone L-Aspartates
- A Saturable Tissue-Angiotensin I Converting Enzyme (ACE) Binding Model for the Pharmacokinetic Analysis of Imidapril, a New ACE Inhibitor, and Its Active Metabolite in Human